Innovative Medicine
-
-
-
Updated Coding and Payment on the Horizon for Circulating Tumor Cell Testing
CMS Action May Provide Increased Access for Patients -
Janssen Healthcare Innovation Launches Care4Today™ Mobile Adherence Medication Reminder Platform
Free, secure mobile app and website designed to improve adherence to treatment regimens through self-directed reminders to take medications, refill prescriptions and visit healthcare providers -
Award-Winning Documentary, The Other City, Returns to Washington, D.C. for AIDS 2012
Janssen Therapeutics sponsors free film screenings and panel discussions with director Susan Koch, film participants and members of the HIV/AIDS community -
-
Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science
$5.4 Million in Funding Part of Healthy Minds Initiative -
-
U.S. FDA Grants Priority Review for XARELTO® (rivaroxaban) Supplemental NDAs for the Treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and the Long-Term Prevention of Recurrent DVT and PE
Company Also Provides Update on Stent Thrombosis sNDA